AusPAR: Eculizumab

Australian Public Assessment Report

AusPAR

AusPAR: Eculizumab [PDF, 535.73 KB]

AusPAR: Eculizumab [Word, 805.68 KB]

Attachment: Product Information for Eculizumab [PDF, 598.8 KB]

Attachment: Product Information for Eculizumab [Word, 256.3 KB]

Device/Product Name

Soliris

Active ingredients

Eculizumab

AusPAR Date

24 November 2020

Published

2 December 2020

Submission Number

PM-2019-04825-1-1

Submission Type

Extension of indications

Decision

Approved